Blackwell Kimberly Insider Trades

Insider Trading History

Track insider trading activity for Blackwell Kimberly. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Director
Holding Value $604k 25,800 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$441k 25,800 shares
$17.10
$23.41
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $161k 74,000 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$166k 74,000 shares
$2.24
$2.17
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Director
Holding Value $719k 30,700 shares
Last Trade
Jun 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 30,700 shares
$4.91
$23.41
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $95.5k 44,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.4k 44,000 shares
$0.60
$2.17
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $95.5k 44,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 44,000 shares
$2.69
$2.17
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Director
Holding Value $517k 22,100 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.9k 22,100 shares
$4.16
$23.41
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Chief Executive Officer
Holding Value $2.31M 484,145 shares
Last Trade
Feb 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$241k 20,655 shares
$11.69
$4.77
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Chief Executive Officer
Holding Value $2.41M 504,800 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.85M 500,000 shares
$11.69
$4.77
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Chief Executive Officer
Holding Value $1.22M 254,800 shares
Last Trade
Nov 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$51.5k 5,000 shares
$10.29
$4.77
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $95.5k 44,000 shares
Last Trade
Jun 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 44,000 shares
$3.19
$2.17
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Director
Holding Value $480k 20,500 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$135k 20,500 shares
$6.59
$23.41
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Chief Executive Officer
Holding Value $1.69M 355,200 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.4M 355,200 shares
$23.65
$4.77
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Director
Holding Value $351k 15,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$115k 15,000 shares
$7.66
$23.41
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $43.1k 19,872 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$340k 39,744 shares
$8.56
$2.17
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
President & CEO
Holding Value $8.15M 1,708,809 shares
Last Trade
May 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.6M 2,563,213 shares
$24.41
$4.77
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $23.9k 5,000 shares
Last Trade
Jan 03, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$83.7k 1,000 shares
$83.74
$4.77
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $28.6k 6,000 shares
Last Trade
Jan 03, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$80.9k 1,000 shares
$80.89
$4.77
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $181k 38,000 shares
Last Trade
Jan 03, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$80.9k 1,000 shares
$80.89
$4.77
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $23.9k 5,000 shares
Last Trade
Dec 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$73.4k 1,000 shares
$73.41
$4.77
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
Director
Holding Value $28.6k 6,000 shares
Last Trade
Dec 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$73.4k 1,000 shares
$73.41
$4.77

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up